Skip to content

Cannabis: all studies

Page 98 of 289: studies 971 to 980 of 2,882, newest first. Back to the cannabis overview

Research

Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.

Psychopharmacology September 2018 Mehrak Javadi-Paydar, Jacques D. Nguyen, Tony M Kerr et al.

Previous studies report sex differences in some, but not all, responses to cannabinoids in rats. The majority of studies use parenteral injection; however, most human use is via smoke inhalation and, increasingly, vapor inhalation. To compare thermoregulatory and locomotor responses to inhaled ∆9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their combination using an e-cigarette-based...

Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats.

Pharmacology, Biochemistry, and Behavior September 2018 Jacques D. Nguyen, Yanabel Grant, Tony M Kerr et al.

A reduced effect of a given dose of ∆9-tetrahydrocannabinol (THC) emerges with repeated exposure to the drug. This tolerance can vary depending on THC dose, exposure chronicity and the behavioral or physiological measure of interest. A novel THC inhalation system based on e-cigarette technology has been recently shown to produce the hypothermic and antinociceptive effects of THC in rats. To...

Highway to hell or magic smoke? The dose-dependence of Δ9-THC in place conditioning paradigms.

Learning & Memory September 2018 Rimas A Kubilius, Paul M Kaplick, Carsten T. Wotjak preprint

The prerequisites for responsible cannabis use are at the heart of current inquiries into cannabis decriminalization by policy makers as well as academic and nonacademic stakeholders at a global scale. Δ9-tetrahydrocannabinol (Δ9-THC), the prime psychoactive compound of the cannabis sativa, as well as cannabimimetics that resemble the pharmacological properties and psychological effects of...

Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.

Biological Psychiatry August 16, 2018 Yan Jouroukhin, Xiaolei Zhu, Alexey V Shevelkin et al.

Background: Although several studies have linked adolescent cannabis use to long-term cognitive dysfunction, there are negative reports as well. The fact that not all users develop cognitive impairment suggests a genetic vulnerability to adverse effects of cannabis, which are attributed to action of Δ9-tetrahydrocannabinol (Δ9-THC), a cannabis constituent and partial agonist of brain...

A naturalistic examination of the perceived effects of cannabis on negative affect.

Journal of Affective Disorders August 1, 2018 Carrie Cuttler, Alexander Spradlin, Ryan J Mclaughlin

Cannabis is commonly used to alleviate symptoms of negative affect. However, a paucity of research has examined the acute effects of cannabis on negative affect in everyday life. The current study provides a naturalistic account of perceived changes in symptoms of depression, anxiety, and stress as a function of dose and concentration of Δ9tetrahydrocannabinol (THC) and cannabidiol (CBD). Data...

Developmental neurocognitive pathway of psychosis proneness and the impact of cannabis use

August 1, 2018 Josiane Bourque

Cette thèse fait la promotion d’une nouvelle approche ciblant le risque de psychose qui consiste à identifier les enfants et les jeunes adolescents de la communauté appartenant à différentes trajectoires développementales d’expériences psychotiques. Une identification très précoce du risque de psychose chez des jeunes de la communauté pourrait ainsi diminuer la période où les symptômes...

Long-Term Stress and Concomitant Marijuana Smoke Exposure Affect Physiology, Behavior and Adult Hippocampal Neurogenesis

Frontiers in Pharmacology July 23, 2018 Kitti Rusznák, Kata Csekő, Zsófia Varga et al. 23 citations

Marijuana is a widely used recreational drug with increasing legalization worldwide for medical purposes. Most experimental studies use either synthetic or plant-derived cannabinoids to investigate the effect of cannabinoids on anxiety and cognitive functions. The aim of this study was to mimic real life situations where young people smoke cannabis regularly to relax from everyday stress....

Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.

Neuropharmacology July 15, 2018 Daniel G Barrus, Timothy W Lefever, Jenny L Wiley

Edible cannabis-infused products are an increasingly popular method of using cannabis in the United States. Yet, preclinical research to determine mechanisms underlying abuse of Δ9-tetrahydrocannabinol (THC), the primary psychoactive constituent of cannabis, has focused primarily on the effects of parenteral administration. The purpose of this study was to examine the rewarding and aversive...

DOI: 10.1016/j.neuropharm.2018.04.018 (opens in new tab) Full text (opens in new tab) Cannabinoid Delta-9-tetrahydrocannabinol Oral Self-administration +1

Development and validation of a Fast gas chromatography/mass spectrometry method for the determination of cannabinoids in Cannabis sativa L

Journal of Food and Drug Analysis July 3, 2018 V. Cardenia, Tullia Gallina Toschi, Simona Scappini et al.

A routine method for determining cannabinoids in Cannabis sativa L. inflorescence, based on Fast gas chromatography coupled to mass spectrometry (Fast GC/MS), was developed and validated. To avoid the decarboxylation of carboxyl group of cannabinoids, different derivatization approaches, i.e. silylation and esterification (diazomethane-mediated), reagents and solvents (pyridine or ethyl...

Marijuana Misadventures in Children: Exploration of a Dose-Response Relationship and Summary of Clinical Effects and Outcomes.

Pediatric Emergency Care July 2018 Justin W Heizer, Laura M Borgelt, Ferras Bashqoy et al.

This study aimed to explore a dose-response relationship of delta-9-tetrahydrocannabinol (THC) in THC-naïve children after unintentional acute exposure and compare clinical outcomes with non-naïve children. A retrospective review was performed on children aged 31 days to 20 years who presented to Children's Hospital Colorado for care related to acute THC toxicity. The children were divided into...